Liver transplantation in HIV-HCV coinfected patients: a case-control study.

Liver transplantation (LT) for hepatitis C virus (HCV)-associated cirrhosis in human immunodeficiency virus (HIV)-infected patients was compared with non-HIV patients. Nine patients with HIV-HCV coinfection were compared with patients transplanted before and after each HIV patient (control group). Immunosuppression consisted in tacrolimus with steroids or mycophenolate mofetil. Acute cellular rejection and three-year actuarial patient survival were respectively 44% and 87.5% in HIV group and 22% and 93.7% in the control group (P=NS). Acute hepatitis C virus occurred earlier (2.3 vs. 4.3 months) and was more cholestatic (mean bilirubin: 10.8 vs. 1.6 mg/dL) in the HIV group. Eight (100%) HIV and nine (64.3%) control patients received antiviral treatment with pegylated interferon and ribavirin. One patient (11.1%) of the control group and one patient (20%) of the HIV group presented a sustained virologic response (P=NS). Short- to midterm results of LT in HIV-HCV co-infected patients were excellent and similar to non-HIV patients.

[1]  I. Bilbao,et al.  A prospective randomized trial comparing tacrolimus and steroids with tacrolimus monotherapy in liver transplantation: the impact on recurrence of hepatitis C , 2005, Transplant international : official journal of the European Society for Organ Transplantation.

[2]  I. Bilbao,et al.  Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation. , 2005, Journal of hepatology.

[3]  José A. Salvador,et al.  Documento de consenso GESIDA/GESITRA-SEIMC, SPNS y ONT sobre trasplante de órgano sólido en pacientes infectados por el VIH en España (marzo 2005) , 2005 .

[4]  D. Samuel,et al.  Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patients. , 2005, Journal of hepatology.

[5]  G. Gerken,et al.  Outcome after orthotopic liver transplantation in five HIV‐infected patients with virus hepatitis‐induced cirrhosis , 2005, Liver international : official journal of the International Association for the Study of the Liver.

[6]  P. Martín-Dávila,et al.  Liver transplantation in HIV‐infected recipients , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[7]  B. Portmann,et al.  Outcomes of liver transplantation in HIV‐infected individuals: The impact of HCV and HBV infection , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[8]  T. Serrano,et al.  Liver transplantation without steroid induction in HIV‐infected patients , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[9]  H. Izzedine,et al.  Antiretroviral and immunosuppressive drug-drug interactions: an update. , 2004, Kidney international.

[10]  M. Vogel,et al.  Management of drug‐to‐drug interactions between cyclosporine A and the protease‐inhibitor lopinavir/ritonavir in liver‐transplanted HIV‐infected patients , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[11]  S. Norris,et al.  Mitochondrial toxicity associated with HAART following liver transplantation in an HIV‐infected recipient , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[12]  J. Pomposelli,et al.  Severe steatosis as the initial histologic manifestation of recurrent hepatitis C genotype 3. , 2004, Human pathology.

[13]  J. Fishman.  Transplantation for patients infected with human immunodeficiency virus: no longer experimental but not yet routine. , 2003, The Journal of infectious diseases.

[14]  N. Heaton,et al.  Survival of human immunodeficiency virus-infected liver transplant recipients. , 2003, The Journal of infectious diseases.

[15]  D. Samuel,et al.  Liver transplantation in patients with HIV infection. , 2003, Journal of hepatology.

[16]  E. Schiff,et al.  Orthotopic liver transplantation in patients with human immunodeficiency virus and end‐stage liver disease , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[17]  J. Berlin,et al.  The association between hepatitis C infection and survival after orthotopic liver transplantation. , 2002, Gastroenterology.

[18]  M. Rela,et al.  Liver transplantation in adults coinfected with HIV. , 2001, Transplantation.

[19]  A. Lafeuillade,et al.  Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection , 2001, The Lancet.

[20]  Nina Singh,et al.  Interactions between tacrolimus and antimicrobial agents. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  Eugene R. Schiff,et al.  National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C , 1997, Hepatology.